Long-Term Follow-Up Results of Adjuvant Intensity-Modulated Radiotherapy with Concurrent Paclitaxel and Cisplatin in High-Risk Endometrial Cancer Patients

Table 4

Grade 3-4 acute toxicity.

AE	Grade 3; (%)	Grade 4; (%)
Gastrointestinal toxicity	8 (3.5%)	0
Hematologic toxicity
Hemoglobin	3 (1%)	4 (2%)
Leukocyte	21 (9%)	14 (6%)
Platelet	2 (1%)	0
Diarrhea	3 (1%)	0
Fatigue	5 (2%)	0
Genitourinary	6 (2.6%)	0
Liver function	1 (1%)	0

AE: adverse event.